ClinicalTrials.Veeva

Menu
C

Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan | Merida, Mexico

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

PF-04965842
PF-06741086
MSB11022
PF04965842
Tofacitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab...

Enrolling
Hemophilia B
Hemophilia A
Drug: PF-06741086

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg

Trial sponsors

Pfizer logo
Fresenius Kabi logo
Merck KGaA (EMD Serono) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems